Characterizing the cancer genome in lung adenocarcinoma
Barbara A. Weir(Dana-Farber Cancer Institute), Michele Sue‐Ann Woo(Dana-Farber Cancer Institute), Gad Getz(Broad Institute), Sven Perner(Brigham and Women's Hospital), Li Ding(New York Genome Center), Rameen Beroukhim(Dana-Farber Cancer Institute), William M. Lin(Dana-Farber Cancer Institute), Michael A. Province, Aldi T. Kraja, Laura A. Johnson(Brigham and Women's Hospital), Kinjal Shah(Broad Institute), Mitsuo Sato(The University of Texas Southwestern Medical Center), Roman K. Thomas(Broad Institute), Justine A. Barletta(Brigham and Women's Hospital), Ingrid B. Borecki, Stephen Broderick, Andrew C. Chang, Derek Y. Chiang(Dana-Farber Cancer Institute), Lucian R. Chirieac(Brigham and Women's Hospital), Jeonghee Cho(Dana-Farber Cancer Institute), Yoshitaka Fujii(Nagoya City University), Adi F. Gazdar(The University of Texas Southwestern Medical Center), Thomas J. Giordano(University of Michigan), Heidi Greulich(Dana-Farber Cancer Institute), Megan Hanna(Broad Institute), Bruce E. Johnson(Dana-Farber Cancer Institute), Mark G. Kris, Alex Lash, Ling Lin(New York Genome Center), Neal I. Lindeman(Brigham and Women's Hospital), Elaine R. Mardis(New York Genome Center), John D. McPherson(Baylor College of Medicine), John D. Minna(The University of Texas Southwestern Medical Center), Margaret Morgan(Baylor College of Medicine), Mark Nadel(Broad Institute), Mark B. Orringer, John R. Osborne(New York Genome Center), Brad Ozenberger(National Institutes of Health), Alex H. Ramos(Broad Institute), James Robinson(Broad Institute), Jack A. Roth, Valerie W. Rusch, Hidefumi Sasaki(Nagoya City University), Frances A. Shepherd(University Health Network), Carrie Sougnez(Broad Institute), Margaret R. Spitz, Ming‐Sound Tsao(University Health Network), David Twomey(Broad Institute), Roel G.W. Verhaak(Broad Institute), George M. Weinstock(Baylor College of Medicine), David A. Wheeler(Baylor College of Medicine), Wendy Winckler(Broad Institute), Akihiko Yoshizawa, Soyoung Yu(Dana-Farber Cancer Institute), Maureen F. Zakowski, Qunyuan Zhang, David G. Beer, Ignacio I. Wistuba, Mark A. Watson(Washington University in St. Louis), Levi A. Garraway(Broad Institute), Marc Ladanyi, William D. Travis, William Pao, Mark A. Rubin(Brigham and Women's Hospital), Stacey Gabriel(Broad Institute), Richard A. Gibbs(Baylor College of Medicine), Harold Varmus(Memorial Sloan Kettering Cancer Center), Richard K. Wilson(New York Genome Center), Eric S. Lander(Harvard University), Matthew Meyerson
Cited by 1,121Open Access